Genmab A (GMAB) Change in Acquisitions & Divestments (2023 - 2026)

Genmab A's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at -$4.0 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 300.0% year-over-year to -$4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.0 million (up 42.11% YoY) and the FY2024 annual result came in at -$8.0 million, down 100.0% from the prior year.
• Change in Acquisitions & Divestments was -$4.0 million for Q1 2026 at Genmab A, down from -$3.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at -$1.0 million in Q1 2025 and bottomed at -$8.0 million in Q4 2024.
• A 4-year average of -$4.0 million and a median of -$4.0 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments surged 66.67% — and 2026, when it plunged 300.0%.
• Genmab A's Change in Acquisitions & Divestments stood at -$4.0 million in 2023, then tumbled by 100.0% to -$8.0 million in 2024, then soared by 62.5% to -$3.0 million in 2025, then slumped by 33.33% to -$4.0 million in 2026.
• Business Quant data shows GMAB's Change in Acquisitions & Divestments at -$4.0 million in Q1 2026, -$3.0 million in Q3 2025, and -$3.0 million in Q2 2025.